Fact 13: MS Impact on Life Expectancy is Moderate
The diagnosis of Multiple Sclerosis (MS) can bring along with it numerous concerns, one of the most pressing being the impact on life expectancy. The longevity of MS patients is a widely researched subject. The comforting news is that life expectancy for most people with MS is nearly the same as the general population, only slightly lower.
Thanks to medical advancements and improved healthcare over the years, MS patients today live significantly longer than they did decades ago. Disease-modifying therapies (DMTs), improved symptomatic treatments, and a better understanding of the disease itself have contributed to enhancing not just the longevity but also the quality of life for those diagnosed with MS.
While the disease’s progression may not significantly impact life expectancy, MS patients tend to be more prone to certain other medical conditions, or comorbidities, such as cardiovascular diseases, respiratory conditions, and infections. These comorbidities can potentially affect an individual’s longevity. Hence, along with managing MS, it is equally crucial to monitor and control these comorbid conditions actively.
Although the focus frequently shifts to life expectancy, it is vital not to lose sight of the quality of life, which is just as important, if not more so. This aspect involves efficient management of symptoms, addressing mental health, and maintaining a positive, fulfilling lifestyle despite the disease. With the right care and management, individuals with MS can lead a fulfilling life.
Continuous research is underway to further improve the quality of life and extend the life expectancy of people with MS. As our understanding of the disease deepens, the approach to its management evolves, raising hope for the future. MS is a challenging journey, but with the right support and care, individuals can navigate this journey and lead a productive life. (13)
